Factory 99% Sorafenib Tosylate Powder CAS 475207-59-1 Anti-Tumor Sorafenib Tosylate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A621
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Sorafenib Tosylate
• CAS: 475207-59-1
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 1g
• Function: Anti-Tumor
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

 

Product Name	Sorafenib Tosylate
Appearance	White Powder
CAS NO.	475207-59-1
MF	C21H16ClF3N4O3S
Storage	Keep in a cool, dry, dark location

 

Sorafenib Tosylate is a derivative of sorafenib, an orally active multikinase inhibitor. It is primarily used in the treatment of certain types of cancer by inhibiting the enzymes involved in tumor cell proliferation and angiogenesis.

 

1. Cancer Treatment: Sorafenib Tosylate is primarily administered to patients with advanced renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer.
2. Combination Therapy: It may be used in combination with other therapeutic agents to enhance the effectiveness of cancer treatment.
3. Adjuvant Therapy: In some cases, it is employed as an adjuvant therapy to prevent the recurrence of cancer after surgical resection.

1. Inhibition of Cell Proliferation: Sorafenib Tosylate functions by inhibiting the tyrosine kinase activity of various enzymes, thereby disrupting the signaling pathways that promote cell growth and division.
2. Antiangiogenic Effects: By inhibiting the formation of new blood vessels (angiogenesis), it helps to starve the tumor of essential nutrients and oxygen, leading to its shrinkage or stabilization.
3. Modulation of Immune Response: It may also modulate the immune response by affecting the activity of immune cells, potentially enhancing the body's ability to combat cancer cells.